Abstract
The etiology of Behçet’s disease (BD) has not been fully elucidated. However, immunological and environmental factors, endothelial dysfunction (ED), and genetic susceptibility have been proposed to play a role. In this study, we aimed to evaluate epicardial fat thickness (EFT) together with serum asymmetric dimethylarginine (ADMA), carotid intima media thickness (CIMT), and neutrophil-to-lymphocyte ratio (NLR) in BD patients with ocular involvement. Thirty-six ocular BD patients (17 active and 19 inactive ocular involvement), and 35 age and sex-matched healthy controls were enrolled to this cross-sectional study. All patients underwent examinations with transthoracic echocardiography and carotid Doppler ultrasound. Serum ADMA levels, CIMT, EFT, and NLR were compared between groups, and their association with disease activity was evaluated. Behçet’s disease patients had higher WBC counts, neutrophil counts, NLR, CIMT, EFT values, and serum ADMA levels than do healthy controls. The other biochemical, hematological, and echocardiographic parameters were comparable between the two groups. Behçet’s disease duration was positively correlated with EFT and CIMT. Multivariate logistic regression analysis revealed that increased serum ADMA concentration and CIMT are independently associated with BD. Neutrophil counts, NLR, and serum ADMA level were higher, and lymphocyte count was lower in patients with active ocular BD compared to those of inactive ocular BD group. Carotid intima media thickness, serum ADMA level, EFT, and NLR were increased in ocular BD patients compared to healthy subjects. In addition, both serum ADMA level and NLR were associated with disease activity of ocular involvement. Increase in disease duration was associated with increase in CIMT and EFT which suggests that anatomical changes occur in time during the disease course. Increased CIMT, serum ADMA level, EFT, and NLR may provide new clues about the role of ED and inflammation in the etiopathogenesis of BD.
Similar content being viewed by others
References
Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341(17):1284–1291
Verity DH, Wallace GR, Vaughan RW, Stanford MR (2003) Behcet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol 87(9):1175–1183
Kapsimali VD, Kanakis MA, Vaiopoulos GA, Kaklamanis PG (2010) Etiopathogenesis of Behcet’s disease with emphasis on the role of immunological aberrations. Clin Rheumatol 29(11):1211–1216
Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M et al (2000) Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102(9):994–999
Maldonado FJ, Miralles Jde H, Aguilar EM, Gonzalez AF, Garcia JR, Garcia FA (2009) Relationship between noninvasively measured endothelial function and peripheral arterial disease. Angiology 60(6):725–731
Yurdakul S, Erdemir VA, Yildirimturk O, Gurel MS, Aytekin S (2012) Evaluation of endothelial functions in patients with Behcet’s disease without overt vascular involvement. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 40(6):518–522
Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T et al (2004) Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 110(18):2918–2923
Boger RH, Maas R, Schulze F, Schwedhelm E (2005) Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chemi Lab Med: CCLM / FESCC 43(10):1124–1129
Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH et al (2005) Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46(3):518–523
Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H et al (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466
Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG et al (2007) Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 116(11):1234–1241
Teijeira-Fernandez E, Eiras S, Grigorian-Shamagian L, Fernandez A, Adrio B, Gonzalez-Juanatey JR (2008) Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension. J Hum Hypertens 22(12):856–863
Ozturk S, Erdem A, Ozlu MF, Ayhan S, Erdem K, Ozyasar M et al (2013) Assessment of the neutrophil to lymphocyte ratio in young patients with acute coronary syndromes. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 41(4):284–289
Demir M (2013) The relationship between neutrophil lymphocyte ratio and non-dipper hypertension. Clin Exp Hypertens 35(8):570–573
No Authors (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335(8697):1078–1080.
Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A et al (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88(11):5163–5168
MacAllister RJ, Fickling SA, Whitley GS, Vallance P (1994) Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol 112(1):43–48
Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Behcet’s syndrome. J Am Coll Cardiol 37(2):517–520
Onur E, Kabaroglu C, Inanir I, Var A, Guvenc Y, Gunay O et al (2011) Oxidative stress impairs endothelial nitric oxide levels in Behcets’ disease. Cutan Ocul Toxicol 30(3):217–220
Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S et al (2005) Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet’s disease. Br J Dermatol 153(3):526–530
Sahin M, Arslan C, Naziroglu M, Tunc SE, Demirci M, Sutcu R et al (2006) Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet’s disease. Ann Clin Lab Sci 36(4):449–454
Franceschelli S, Ferrone A, Pesce M, Riccioni G, Speranza L (2013) Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease. Int J Mol Sci 14(12):24412–24421
Yilmaz MI, Demirkaya E, Acikel C, Saldir M, Akar S, Cayci T et al (2014) Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events. Rheumatology 53(11):2002–2008
Lu TM, Chung MY, Lin MW, Hsu CP, Lin SJ (2011) Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography. Int J Cardiol 153(2):135–140
Gunebakmaz O, Duran M, Karakaya E, Tanrikulu E, Akpek M, Ergin A et al (2013) Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 41(7):581–588
Onat A, Hergenc G, Can G, Karabulut A (2008) Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers. Turk Kardiyoloji Dernegi arsivi Turk Kardiyoloji Derneginin yayin organidir 36(1):7–13
Celik M, Cerrah S, Arabul M, Akalin A (2014) Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients. J Diabetes Res 2014:139215
Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M (2002) Increased nitric oxide production in patients with Behcet’s disease: is it a new activity marker? J Am Acad Dermatol 46(1):50–54
Kiraz S, Ertenli I, Calguneri M, Ozturk MA, Haznedaroglu IC, Altun B et al (2001) Interactions of nitric oxide and superoxide dismutase in Behcet’s disease. Clin Exp Rheumatol 19(5 Suppl 24):S25–S29
Ozuguz P, Karabulut AA, Tulmac M, Kisa U, Kocak M, Gunduz O (2014) Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behcet Disease. Angiology 65(10):937–943
Kayikcioglu M, Aksu K, Hasdemir C, Keser G, Turgan N, Kultursay H et al (2006) Endothelial functions in Behcet’s disease. Rheumatol Int 26(4):304–308
Ulusoy RE, Karabudak O, Kilicaslan F, Kirilmaz A, Us MH, Cebeci BS (2008) Noninvasive assessment of impaired endothelial dysfunction in mucocutaneous Behcet’s disease. Rheumatol Int 28(7):617–621
Alan S, Ulgen MS, Akdeniz S, Alan B, Toprak N (2004) Intima-media thickness and arterial distensibility in Behcet’s disease. Angiology 55(4):413–419
Hong SN, Park JC, Yoon NS, Lee SR, Kim KH, Hong YJ et al (2008) Carotid artery intima-media thickness in Behcet’s disease patients without significant cardiovascular involvement. Korean J Intern Med 23(2):87–93
O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340(1):14–22
Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146(6):483–494
Iacobellis G, Barbaro G (2008) The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res 40(7):442–445
Kaya H, Ertas F, Oylumlu M, Bilik MZ, Yildiz A, Yuksel M et al (2013) Relation of epicardial fat thickness and brachial flow-mediated vasodilation with coronary artery disease. J Cardiol 62(6):343–347
Oylumlu M, Ozler A, Yildiz A, Oylumlu M, Acet H, Polat N et al (2014) New inflammatory markers in pre-eclampsia: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio. Clin Exp Hypertens 36(7):503–507
Kim BJ, Kim BS, Kang JH (2013) Echocardiographic epicardial fat thickness is associated with arterial stiffness. Int J Cardiol 167(5):2234–2238
Acknowledgments
The authors would like to express their appreciation to Dicle University DUBAP department for their sponsorship during Elisa kit attainment.
Disclosure
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuksel, M., Yildiz, A., Oylumlu, M. et al. Novel markers of endothelial dysfunction and inflammation in Behçet’s disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio. Clin Rheumatol 35, 701–708 (2016). https://doi.org/10.1007/s10067-015-2907-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-2907-0